We are live on ! Find out more
CPIX icon

Cumberland Pharmaceuticals
CPIX

45 hedge funds and large institutions have $29.4M invested in Cumberland Pharmaceuticals in 2013 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 21 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% less capital invested

Capital invested by funds: $33.9M → $29.4M (-$4.42M)

25% less funds holding

Funds holding: 60 → 45 (-15)

57% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 21

75% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 20

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $5K

Holders
45
Holders Change
-15
Holders Change %
-25%
% of All Funds
1.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
9
Reduced
21
Closed
20
Calls
–
Puts
$5K
Net Calls
-$5K
Net Calls Change
+$2K

Top Buyers

Rank Fund Capital Flow
1
AI
Ariel Investments
Illinois
+$1.66M
2
BG
BlackRock Group
United Kingdom
+$660K
3
PCM
Perritt Capital Management
Illinois
+$554K
4
BIT
BlackRock Institutional Trust
California
+$549K
5
BCM
Bridgeway Capital Management
Texas
+$336K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$480K
2
Northern Trust
Northern Trust
Illinois
-$454K
3
HighTower Advisors
HighTower Advisors
Illinois
-$386K
4
Renaissance Technologies
Renaissance Technologies
New York
-$364K
5
Deutsche Bank
Deutsche Bank
Germany
-$287K
Name Holding Trade Value Shares
Change 		Change in
Stake
Wellington Management Group
26
Wellington Management Group
Massachusetts
$125K – – –
Northern Trust
27
Northern Trust
Illinois
$112K -$454K -91,104 -79%
Two Sigma Investments
28
Two Sigma Investments
New York
$108K -$6.47K -1,300 -5%
SIM
29
Spark Investment Management
New York
$91K -$92.1K -18,500 -48%
State Street
30
State Street
Massachusetts
$89K -$11.9K -2,400 -11%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$79K +$6.6K +1,325 +8%
Deutsche Bank
32
Deutsche Bank
Germany
$72K -$287K -57,561 -78%
DAM
33
Delta Asset Management
Tennessee
$50K – – –
Nomura Holdings
34
Nomura Holdings
Japan
$48K +$52.3K +10,500 New
WA
35
WealthTrust-Arizona
Arizona
$40K – – –
CCMH
36
Cornerstone Capital Management Holdings
New York
$27K +$15.9K +3,200 +119%
U
37
UBS
Switzerland
$21K -$46.3K -9,308 -67%
Citigroup
38
Citigroup
New York
$21K -$1.3K -261 -5%
PNC Financial Services Group
39
PNC Financial Services Group
Pennsylvania
$19K – – –
NFA
40
Nationwide Fund Advisors
Ohio
$17K -$26.1K -5,236 -58%
TRCT
41
Tower Research Capital (TRC)
New York
$8K +$5.33K +1,071 +174%
Bank of America
42
Bank of America
North Carolina
$4K -$128K -25,649 -97%
Group One Trading
43
Group One Trading
Illinois
$2K – – –
HF
44
Hoxton Financial
West Virginia
$1K +$1.33K +268 New
Manulife (Manufacturers Life Insurance)
45
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$3 – – –
HighTower Advisors
46
HighTower Advisors
Illinois
– -$386K -75,577 Closed
PP
47
Paloma Partners
Connecticut
– -$245K -47,979 Closed
RJA
48
Raymond James & Associates
Florida
– -$242K -47,366 Closed
SKK
49
Shepherd Kaplan Krochuk
Massachusetts
– -$212K -41,500 Closed
Citadel Advisors
50
Citadel Advisors
Florida
– -$199K -38,959 Closed
1
2
3

CPIX Hedge Fund Activity: Q3 2013 in Review

45 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q3 2013, worth a combined $29.4M — down 13% from $33.9M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of CPIX and 5 opened new positions — a net loss of 15 holders — while 21 trimmed existing stakes and 9 added.

The largest buyer was Ariel Investments, adding an estimated $1.66M. The largest seller was Morgan Stanley, cutting an estimated $480K.

  • 45 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q3 2013, down from 60 in Q2 2013.
  • Funds reported $29.4M of Cumberland Pharmaceuticals stock for Q3 2013, down 13% quarter-over-quarter.
  • 5 funds opened new Cumberland Pharmaceuticals positions in Q3 2013 and 20 closed out, a net change of -15 holders.
  • The largest Cumberland Pharmaceuticals buyer in Q3 2013 was Ariel Investments, an estimated $1.66M added.
  • The largest Cumberland Pharmaceuticals seller in Q3 2013 was Morgan Stanley, an estimated $480K sold.

Based on aggregated 13F filings for Q3 2013.